Target Engagement Analysis and Link to Pharmacodynamic Endpoint for a Novel Class of CNS-penetrant and Efficacious p38α MAPK Inhibitors
Crossref DOI link: https://doi.org/10.1007/s11481-014-9543-3
Published Online: 2014-05-01
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bachstetter, Adam D.
Watterson, D. Martin
Van Eldik, Linda J.
License valid from 2014-05-01